{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825895299198720.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1093/bja/aer115"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S000709121733146X?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S000709121733146X?httpAccept=text/plain"}},{"identifier":{"@type":"URI","@value":"http://academic.oup.com/bja/article-pdf/107/1/8/938669/aer115.pdf"}}],"dc:title":[{"@value":"Opioid receptor subtypes: fact or artifact?"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380572092452366465","@type":"Researcher","foaf:name":[{"@value":"N. Dietis"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895299198720","@type":"Researcher","foaf:name":[{"@value":"D.J. Rowbotham"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895299198593","@type":"Researcher","foaf:name":[{"@value":"D.G. Lambert"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00070912"}],"prism:publicationName":[{"@value":"British Journal of Anaesthesia"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2011-07","prism:volume":"107","prism:number":"1","prism:startingPage":"8","prism:endingPage":"18"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license","http://www.elsevier.com/open-access/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S000709121733146X?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S000709121733146X?httpAccept=text/plain"},{"@id":"http://academic.oup.com/bja/article-pdf/107/1/8/938669/aer115.pdf"}],"createdAt":"2011-05-25","modifiedAt":"2025-09-13","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050011340343797888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002215878620928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"New vistas in opioid control of pain"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017282468648448","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Inhibitory Effects of a Novel μ-Opioid Receptor Nonpeptide Antagonist, UD-030, on Morphine-Induced Conditioned Place Preference"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707094110976","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Stimulation of accumbal GABAB receptors inhibits delta1- and delta2-opioid receptor-mediated dopamine efflux in the nucleus accumbens of freely moving rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182070712960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"In vivo neurochemical evidence that delta1-, delta2- and mu2-opioid receptors, but not mu1-opioid receptors, inhibit acetylcholine efflux in the nucleus accumbens of freely moving rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657047484416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Stimulation of accumbal GABAA receptors inhibits delta2-, but not delta1-, opioid receptor-mediated dopamine efflux in the nucleus accumbens of freely moving rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567364328960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Integrative opioid-GABAergic neuronal mechanisms regulating dopamine efflux in the nucleus accumbens of freely moving animals"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205047465600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Mechanisms underlying δ- and μ-opioid receptor agonist-induced increases in extracellular dopamine level in the nucleus accumbens of freely moving rats"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1093/bja/aer115"},{"@type":"CROSSREF","@value":"10.3390/ijms24043351_references_DOI_2KhOqD2XsVvMN6F13tehkrcTUCn"},{"@type":"CROSSREF","@value":"10.1016/j.ejphar.2018.08.003_references_DOI_2KhOqD2XsVvMN6F13tehkrcTUCn"},{"@type":"CROSSREF","@value":"10.1016/j.ejphar.2017.09.019_references_DOI_2KhOqD2XsVvMN6F13tehkrcTUCn"},{"@type":"CROSSREF","@value":"10.1038/s41598-021-88118-6_references_DOI_2KhOqD2XsVvMN6F13tehkrcTUCn"},{"@type":"CROSSREF","@value":"10.2334/josnusd.16-0874_references_DOI_2KhOqD2XsVvMN6F13tehkrcTUCn"},{"@type":"CROSSREF","@value":"10.1007/s43440-021-00249-9_references_DOI_2KhOqD2XsVvMN6F13tehkrcTUCn"},{"@type":"CROSSREF","@value":"10.1016/j.ejphar.2016.07.028_references_DOI_2KhOqD2XsVvMN6F13tehkrcTUCn"},{"@type":"CROSSREF","@value":"10.1016/j.coph.2011.10.020_references_DOI_2KhOqD2XsVvMN6F13tehkrcTUCn"}]}